Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Eif5a2em1/Cya
Common Name:
Eif5a2-KO
Product ID:
S-KO-17917
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Eif5a2-KO
Strain ID
KOCMP-208691-Eif5a2-B6J-VB
Gene Name
Eif5a2
Product ID
S-KO-17917
Gene Alias
9630038B20; eIF5AII
Background
C57BL/6JCya
NCBI ID
208691
Modification
Conventional knockout
Chromosome
3
Phenotype
MGI:1933735
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Eif5a2em1/Cya mice (Catalog S-KO-17917) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000060500
NCBI RefSeq
NM_177586
Target Region
Exon 2~3
Size of Effective Region
~2.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Eif5a2, the eukaryotic initiation factor 5A2 gene, is a highly conserved and multifunctional gene. It significantly influences various cellular processes such as translation elongation, RNA binding, ribosome binding, protein binding, and post-translational modifications. It is involved in multiple molecular pathways, with its overexpression frequently observed in multiple cancers where it functions as an oncoprotein, and also implicated in drug resistance [1].

Eif5a2-related functional studies show that its knockdown in various cancer cell lines leads to significant impacts. In intrahepatic cholangiocarcinoma cells, high levels of Eif5a2 promote cell proliferation, migration, and invasion by activating the PI3K/AKT/mTOR signaling pathway [2]. In epithelial ovarian cancer cells, knockdown of Eif5a2 reduces the expression of stem-related markers, inhibits self-renewal ability, improves chemosensitivity, and inhibits tumorigenesis in vivo, indicating its positive regulation of stemness via the E2F1/KLF4 pathway [3]. In cervical cancer cells, Eif5a2 knockdown inhibits cell proliferation, migration, and invasion, promotes apoptosis, and enhances cisplatin sensitivity, with its effect mediated through AGR2 [4]. In bladder cancer cells, Eif5a2 promotes doxorubicin resistance through the TGF-β signaling pathway, and its knockdown reverses this effect [5]. In ovarian cancer, knockout of Eif5a2 inhibits epithelial-to-mesenchymal transition (EMT), cell migration, invasion, tumor growth, and metastasis, while overexpression promotes these processes by activating the TGFβ pathway [6]. In oral cancer SCC-9 cells, targeting Eif5a2 reduces invasion and migration, promotes apoptosis, increases chemosensitivity, and upregulates Bim and E-cadherin [7]. In anaplastic thyroid carcinoma, targeting Eif5a2 with shRNA induces cell death in vitro and in vivo, downregulating p-Smad2/3, while overexpression promotes cell growth and upregulates p-Smad3 [8].

In conclusion, Eif5a2 is a crucial gene involved in multiple cellular regulatory processes and plays a significant role in tumorigenesis and drug resistance in various cancers. Gene knockout and knockdown models in cancer cell lines and in vivo mouse models have revealed its functions in promoting cancer cell proliferation, invasion, metastasis, stemness, and drug resistance through different signaling pathways, providing potential therapeutic targets for cancer treatment.

References:
1. Xiong, Xifeng, Du, Yanli, Liu, Peng, Miao, Haixiong, Ning, Bo. 2025. Unveiling EIF5A2: A multifaceted player in cellular regulation, tumorigenesis and drug resistance. In European journal of pharmacology, 997, 177596. doi:10.1016/j.ejphar.2025.177596. https://pubmed.ncbi.nlm.nih.gov/40194645/
2. Yang, Shao-Hua, Hu, Sheng, Kang, Qiang, Zou, Hao, Zhang, Xiao-Wen. 2022. EIF5A2 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells. In Clinics and research in hepatology and gastroenterology, 46, 101991. doi:10.1016/j.clinre.2022.101991. https://pubmed.ncbi.nlm.nih.gov/35792239/
3. Wang, Kun, Wang, Yiyang, Wang, Yuanjian, Zhang, Tianli, Yang, Xingsheng. 2021. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis. In Stem cell research & therapy, 12, 186. doi:10.1186/s13287-021-02256-2. https://pubmed.ncbi.nlm.nih.gov/33726845/
4. Shen, Xin, Li, Lingxia, He, Yuanyuan, Lv, Xiaohui, Ma, Jiajia. 2022. EIF5A2 Is Involved in the Biological Process of Cervical Cancer Cells through AGR2. In Pharmacology, 107, 376-385. doi:10.1159/000524017. https://pubmed.ncbi.nlm.nih.gov/35640539/
5. Yang, Jinsong, Jiang, Xue, Chen, Ying, Teng, Lisong. . EIF5A2 Promotes Doxorubicin Resistance in Bladder Cancer Cells through the TGF-β Signaling Pathway. In Discovery medicine, 35, 1167-1176. doi:10.24976/Discov.Med.202335179.113. https://pubmed.ncbi.nlm.nih.gov/38058082/
6. Zhao, Guannan, Zhang, Wenjing, Dong, Peixin, Tigyi, Gabor, Yue, Junming. 2021. EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway. In Cell & bioscience, 11, 70. doi:10.1186/s13578-021-00578-5. https://pubmed.ncbi.nlm.nih.gov/33827661/
7. Gao, Jinbo, Li, Peng. 2023. Targeting eIF5A2 reduces invasion and reverses chemoresistance in SCC-9 cells in vitro. In Histology and histopathology, 39, 463-470. doi:10.14670/HH-18-637. https://pubmed.ncbi.nlm.nih.gov/37334930/
8. Hao, Fengyun, Zhu, Qingli, Lu, Lingwei, Jiao, Xuelong, Chen, Dong. 2020. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals. In Oncology research, 28, 345-355. doi:10.3727/096504020X15834065061807. https://pubmed.ncbi.nlm.nih.gov/32138807/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest